When innovation aims to reduce antibiotic resistance from a superbacteria

Researchers from the Blas Cabrera Institute of Physical Chemistry (IQF-CSIC) and the University of Notre Dame (Indiana, USA) have identified a compound that blocks the ability of Staphylococcus aureus bacteria to survive antibiotics.This pathogen is considered a superbacteria due to its ability to develop mechanisms that allow it to dodge the action of multiple antibiotics, a phenomenon that is known as resistance, and that makes it difficult to…

This pathogen is considered a superbacteria because of its ability to develop mechanisms that allow it to dodge the action of multiple antibiotics, a phenomenon that is known as resistance, and that makes it difficult to treat the infections it causes, some of them life-threatening. In particular, strains of S. aureus resistant to the antibiotic meticillin (MRSA) are especially problematic because they have extended their resistance to a wide ra…